In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorlular, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial r
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS